Côd QR

High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils

High-grade serious ovarian cancer (HGSOC) is an aggressive malignancy that remains refractory to current immunotherapies. While advanced stage disease has been extensively studied, the cellular and molecular mechanisms that promote early immune escape in HGSOC remain largely unexplored. Here, we rep...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Alexander Emmanuelli, Camilla Salvagno, Sung-Min Hwang, Deepika Awasthi, Tito A. Sandoval, Chang-Suk Chae, Jin-Gyu Cheong, Chen Tan, Takao Iwawaki, Juan R. Cubillos-Ruiz
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis Group 2024-12-01
Cyfres:OncoImmunology
Pynciau:
ER stress
immunotherapy
IRE1
neutrophils
ovarian cancer
PD-1 blockade
Mynediad Ar-lein:https://www.tandfonline.com/doi/10.1080/2162402X.2024.2411070
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg